These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
221 related items for PubMed ID: 21218087
1. MiRNA profile in esophageal squamous cell carcinoma: downregulation of miR-143 and miR-145. Wu BL, Xu LY, Du ZP, Liao LD, Zhang HF, Huang Q, Fang GQ, Li EM. World J Gastroenterol; 2011 Jan 07; 17(1):79-88. PubMed ID: 21218087 [Abstract] [Full Text] [Related]
2. miR-145, miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma. Kano M, Seki N, Kikkawa N, Fujimura L, Hoshino I, Akutsu Y, Chiyomaru T, Enokida H, Nakagawa M, Matsubara H. Int J Cancer; 2010 Dec 15; 127(12):2804-14. PubMed ID: 21351259 [Abstract] [Full Text] [Related]
8. MicroRNA-615-5p targets insulin-like growth factor 2 and exerts tumor-suppressing functions in human esophageal squamous cell carcinoma. Yang B, Xie R, Wu SN, Gao CC, Yang XZ, Zhou JF. Oncol Rep; 2018 Jan 15; 39(1):255-263. PubMed ID: 29115555 [Abstract] [Full Text] [Related]
9. MiRNA-205 modulates cellular invasion and migration via regulating zinc finger E-box binding homeobox 2 expression in esophageal squamous cell carcinoma cells. Matsushima K, Isomoto H, Yamaguchi N, Inoue N, Machida H, Nakayama T, Hayashi T, Kunizaki M, Hidaka S, Nagayasu T, Nakashima M, Ujifuku K, Mitsutake N, Ohtsuru A, Yamashita S, Korpal M, Kang Y, Gregory PA, Goodall GJ, Kohno S, Nakao K. J Transl Med; 2011 Mar 22; 9():30. PubMed ID: 21426561 [Abstract] [Full Text] [Related]
10. MiR-130b plays an oncogenic role by repressing PTEN expression in esophageal squamous cell carcinoma cells. Yu T, Cao R, Li S, Fu M, Ren L, Chen W, Zhu H, Zhan Q, Shi R. BMC Cancer; 2015 Jan 31; 15():29. PubMed ID: 25637514 [Abstract] [Full Text] [Related]
12. Downregulation of MicroRNA-644a Promotes Esophageal Squamous Cell Carcinoma Aggressiveness and Stem Cell-like Phenotype via Dysregulation of PITX2. Zhang JX, Chen ZH, Xu Y, Chen JW, Weng HW, Yun M, Zheng ZS, Chen C, Wu BL, Li EM, Fu JH, Ye S, Xie D. Clin Cancer Res; 2017 Jan 01; 23(1):298-310. PubMed ID: 27407092 [Abstract] [Full Text] [Related]
14. Upregulation of miR-494 Inhibits Cell Growth and Invasion and Induces Cell Apoptosis by Targeting Cleft Lip and Palate Transmembrane 1-Like in Esophageal Squamous Cell Carcinoma. Zhang R, Chen X, Zhang S, Zhang X, Li T, Liu Z, Wang J, Zang W, Wang Y, Du Y, Zhao G. Dig Dis Sci; 2015 May 01; 60(5):1247-55. PubMed ID: 25480402 [Abstract] [Full Text] [Related]
15. MiR-99a suppresses proliferation, migration and invasion of esophageal squamous cell carcinoma cells through inhibiting the IGF1R signaling pathway. Mei LL, Qiu YT, Huang MB, Wang WJ, Bai J, Shi ZZ. Cancer Biomark; 2017 Dec 06; 20(4):527-537. PubMed ID: 28800315 [Abstract] [Full Text] [Related]
16. Identification of novel molecular targets regulated by tumor suppressive miR-375 induced by histone acetylation in esophageal squamous cell carcinoma. Isozaki Y, Hoshino I, Nohata N, Kinoshita T, Akutsu Y, Hanari N, Mori M, Yoneyama Y, Akanuma N, Takeshita N, Maruyama T, Seki N, Nishino N, Yoshida M, Matsubara H. Int J Oncol; 2012 Sep 06; 41(3):985-94. PubMed ID: 22752059 [Abstract] [Full Text] [Related]
17. The tumor-suppressive function of miR-1 by targeting LASP1 and TAGLN2 in esophageal squamous cell carcinoma. Du YY, Zhao LM, Chen L, Sang MX, Li J, Ma M, Liu JF. J Gastroenterol Hepatol; 2016 Feb 06; 31(2):384-93. PubMed ID: 26414725 [Abstract] [Full Text] [Related]
18. Down-Regulation of MiR-1294 is Related to Dismal Prognosis of Patients with Esophageal Squamous Cell Carcinoma through Elevating C-MYC Expression. Liu K, Li L, Rusidanmu A, Wang Y, Lv X. Cell Physiol Biochem; 2015 Feb 06; 36(1):100-10. PubMed ID: 25925090 [Abstract] [Full Text] [Related]
19. Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma. Gao Y, Yi J, Zhang K, Bai F, Feng B, Wang R, Chu X, Chen L, Song H. J Exp Clin Cancer Res; 2017 Nov 16; 36(1):161. PubMed ID: 29145896 [Abstract] [Full Text] [Related]